A media briefing with experts from the Infectious Diseases Society of America to discuss coronavirus and COVID-19 developments and answer questions.
Topical Agenda for June 26 Briefing:
- IDSA’s updated treatment guidelines for frontline clinicians
- What new treatment options for COVID-19 are included in the guidelines?
- What are the latest developments in clinical trials?
- What does the future hold for COVID-19 treatment research?
- Questions from media
FEATURING:
Rajesh T. Gandhi, MD, FIDSA—Boston, MA
Member, IDSA COVID-19 Treatment and Management Guidelines Expert Panel
Fellow, Infectious Diseases Society of America
Chair-Elect, HIV Medicine Association
Professor of Medicine, Harvard Medical School
Director of HIV Clinical Services and Education, Massachusetts General Hospital
Shmuel Shoham, MD, FIDSA—Baltimore, MD
Member, IDSA COVID-19 Treatment and Management Guidelines Expert Panel
Fellow, Infectious Diseases Society of America
Associate Professor of Medicine, Johns Hopkins University School of Medicine
Associate Director, Transplant and Oncology Infectious Diseases Center, Johns Hopkins University School of Medicine
Chris Busky, CAE (Moderator)
Chief Executive Officer—Infectious Diseases Society of America
